Clik here to view.
武田薬品工業：2020年度は力強い利益率と強固なキャッシュ・フローとともに安定的な業績を達成、2021年度には実質的な売上収益成長のさらなる加速を見込
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社は、本日、2020年度の業績を公表しましたのでお知らせします 。 当社代表取締役社長CEOのクリストフ・ウェバーは次のように述べています。...
View ArticleClik here to view.
マグバイオ・ジェノミクスがMawi iSWAB-RNA v2向けにThermofisher KingFisher™...
米カリフォルニア州ヘイワード （ビジネスワイヤ） — 生体試料調製のための革新的な技術の開発に傾注しているバイオテクノロジー企業のマウィDNAテクノロジーズは、マグバイオ・ジェノミクスが同社のHighPrep™ Total RNA Isolation Kit – iSWAB™（HighPrep™トータルRNA分離キット – iSWAB™）を用いて、Thermofisher...
View ArticleClik here to view.
Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory...
SAN DIEGO Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in...
View ArticleClik here to view.
MagBio Genomics Inc.面向Mawi iSWAB-RNA v2开发用于Thermofisher KingFisher™...
加州海沃德 (美国商业资讯)–专注于开发生物采样创新技术的生物技术公司Mawi DNA Technologies宣布，MagBio Genomics通过其HighPrep™ Total RNA Isolation Kit-iSWAB™成功开发出一种面向iSWAB-RNA v2且用于Thermofisher KingFisher™ Flex平台的自动RNA纯化方法。 Mawi DNA...
View ArticleClik here to view.
武田2020财年业绩保持韧性，利润率和现金流均表现强劲；基础营收增长预计在2021财年加速
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited) (TOKYO:4502) (NYSE:TAK)（简称“武田”）今天公布了2020财年财务业绩（截至2021年3月31日）。 武田总裁兼首席执行官CHRISTOPHE WEBER表示：...
View ArticleClik here to view.
Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s...
CAMBRIDGE, Mass. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of Health, Labour and Welfare...
View ArticleClik here to view.
イルミナとマイクローバ・ライフ・サイエンシズが微生物叢研究を加速化すべく提携
豪メルボルン （ビジネスワイヤ） — DNAシーケンシングおよびアレイベース技術の世界的リーダー企業であるイルミナは本日、ヒトの健康と疾患にかかわるヒト腸内微生物叢の理解を深めるため、精密腸内微生物叢科学のリーダー企業であるマイクローバ・ライフ・サイエンシズと提携したと発表しました。...
View ArticleClik here to view.
Engine Biosciences宣布获得超额认购的4300万美元A轮融资，以通过机器学习和新一代组合遗传学破译新药开发遗传密码
新加坡和美国加利福尼亚州圣卡洛斯 Engine Biosciences（“Engine”）于今日宣布成功完成超额认购的4300万美元A轮融资。Engine公司能识别出复杂疾病遗传密码中的错误，并用精确的治疗方案对其进行修复。本轮融资由Polaris...
View ArticleClik here to view.
Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic...
SINGAPORE & SAN CARLOS, Calif. Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies errors in the...
View ArticleClik here to view.
Available Now! Whitepaper: Advancing Drug Discovery Through DNA Encoded...
CHENGDU, China HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the drug discovery...
View ArticleClik here to view.
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution...
MELBOURNE, Australia Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations...
View ArticleClik here to view.
Clik here to view.
Veristat Appoints Colleen Pelton Chief Talent Officer
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Colleen Pelton to the role of Chief Talent Officer. Ms. Pelton joins...
View ArticleClik here to view.
Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across...
TOKYO, MUNICH & BASKING RIDGE, N.J. New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo’s) patritumab deruxtecan (HER3-DXd), a HER3 directed antibody drug conjugate (ADC),...
View ArticleClik here to view.
Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration...
SAN DIEGO & CAMBRIDGE, Mass. & BEIJING Shoreline Biosciences, Inc., a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural...
View ArticleClik here to view.
Valemetostat Data at EHA Shows Promising Durable Tumor Response in Patients...
TOKYO & MUNICH & BASKING RIDGE, N.J. New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) for valemetostat, a potential first-in-class specific and potent dual inhibitor...
View ArticleClik here to view.
Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education...
MELBOURNE, Australia & INDIANAPOLIS Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announced the launch of TelixU, a new educational platform focused on radiopharmaceutical...
View ArticleClik here to view.
Kite Joint Venture – Fosun Kite – Gains the First CAR T-cell Therapy Approval...
SANTA MONICA, Calif. Kite, a Gilead Company, announced that Fosun Kite Biotechnology Co., Ltd., a joint venture between Kite and Shanghai Fosun Pharmaceutical (Group) Co., Ltd, has received approval...
View ArticleClik here to view.
ImmunoScape Expands its Executive and Scientific Teams to Extend Use of its...
SINGAPORE & SAN DIEGO ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has made three...
View Article